Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SHE/301290 stock hub

SHE/301290 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/301290is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.1B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/301290
In the news

Latest news · SHE/301290

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/E65.4
P25 23.5P50 41.3P75 83.2
ROE10.9
P25 -0.9P50 4.1P75 8.8
ROIC13.8
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/301290 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
219
Groups with data
11
Currency
CNY
Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
703
Employees Change
57%
Employees Change Percent
8.82
Enterprise value
CNY 2B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Medical Devices
Isin
CNE1000065F2
Last refreshed
2026-05-10
Market cap
CNY 3.1B
Price
CNY 31.49
Price currency
CNY
Rev Per Employee
5,603,580.64x
Sector
Healthcare
Sic
3845
Symbol
she/301290
Website
https://www.dx-med.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
7.81%
EV Earnings
8.17x
EV/EBIT
7.66x
EV/EBITDA
5.71x
EV/FCF
1.41x
EV/Sales
0.5x
FCF yield
45.33%
P/B ratio
1.43x
P/E ratio
65.35x
P/S ratio
0.79x
PE Ratio3 Y
18.63x
PE Ratio5 Y
21.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
6.57%
EBITDA Margin
8.74%
FCF margin
35.76%
Gross margin
11.21%
Gross Profit
CNY 441.7M
Gross Profit Growth
-4.31%
Gross Profit Growth Q
30.89%
Gross Profit Growth3 Y
26.34%
Gross Profit Growth5 Y
23.01%
Net Income
CNY 242.6M
Net Income Growth
-16.81%
Net Income Growth Q
48.51%
Net Income Growth3 Y
35.06%
Net Income Growth5 Y
38.17%
Pretax Margin
6.28%
Profit Margin
6.16%
Profit Per Employee
CNY 345,031
ROA
6.62
Roa5y
4.3
ROCE
11.83
ROE
10.93
Roe5y
7.62
ROIC
13.77
Roic5y
10.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr1y
40.51%
Cagr3y
1.86%
EPS Growth
-17.49
EPS Growth Q
50
EPS Growth3 Y
-25.92
EPS Growth5 Y
-12.01
FCF Growth
-39.9%
FCF Growth3 Y
322.44%
FCF Growth5 Y
118.88%
OCF Growth
-34.94%
OCF Growth3 Y
148.7%
OCF Growth5 Y
109.21%
Revenue Growth
-7.71x
Revenue Growth Q
15.71x
Revenue Growth3 Y
108.63x
Revenue Growth5 Y
68.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
CNY 1.61
Assets
CNY 2.4B
Cash
CNY 1.2B
Current Assets
CNY 1.5B
Current Liabilities
CNY 217.8M
Debt
CNY 114.5M
Debt EBITDA
CNY 0.33
Debt Equity
CNY 0.05
Debt FCF
CNY 0.08
Equity
CNY 2.2B
Interest Coverage
36.6
Liabilities
CNY 232.8M
Long Term Assets
CNY 937.1M
Long Term Liabilities
CNY 15M
Net Cash
CNY 1.1B
Net Cash By Market Cap
CNY 36.44
Net Cash Growth
-0.02%
Net Debt EBITDA
CNY -3.29
Net Debt Equity
CNY -0.52
Net Debt FCF
CNY -0.8
Tangible Book Value
CNY 1.7B
Tangible Book Value Per Share
CNY 16.91
WACC
8.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.74
Inventory Turnover
29.67
Net Working Capital
CNY 116.4M
Quick ratio
6.17
Working Capital
CNY 1.3B
Working Capital Turnover
CNY 3.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.82%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
CNY 0.24
Dividend Years
3
Dividend Yield
0.76%
Ex Div Date
2025-05-15
Last Dividend
CNY 0.6
Payout Frequency
Annual
Payout Ratio
64.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
40.47%
200-day SMA
27.32
3Y total return
5.69%
50-day SMA
27.98
50-day SMA vs 200-day SMA
50over200
All Time High
59
All Time High Change
-46.63%
All Time High Date
2022-11-30
All Time Low
16.6
All Time Low Change
89.7%
All Time Low Date
2024-02-06
ATR
1.06
Beta
0.7
Beta1y
0.48
Beta2y
0.58
Ch YTD
24.61
High
32
High52
31.49
High52 Date
2026-05-08
High52ch
0%
Low
30.43
Low52
22.3
Low52 Date
2025-05-08
Low52ch
41.21%
Ma50ch
12.56%
Price vs 200-day SMA
15.27%
RSI
69.29
RSI Monthly
52.96
RSI Weekly
65.77
Sharpe ratio
1.03x
Sortino ratio
1.85
Total Return
-0.06%
Tr YTD
24.61
Tr1m
17.06%
Tr1w
3.48%
Tr3m
8.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 258.8M
Operating Income Growth
-13.01
Operating Income Growth Q
85.11
Operating Income Growth3 Y
37.85
Operating Income Growth5 Y
33.64
Operating margin
6.57

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
55,906,905%
Net Borrowing
-1,432,003,952
Shares Insiders
37.64%
Shares Institutions
11.97%
Shares Out
98,680,683
Shares Qo Q
-94.19%
Shares Yo Y
0.82%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
CNY 1.4B
Average Volume
2,561,997.55x
Bv Per Share
21.94
CAPEX
CNY -160.1M
Ch1m
17.06
Ch1w
3.48
Ch1y
37.03
Ch3m
8.62
Ch3y
-1.32
Ch6m
18.83
Change
4.2%
Change From Open
3.48
Close
30.22
Days Gap
0.69
Depreciation Amortization
85,382,388
Dollar Volume
174,188,604
Earnings Date
2026-04-21
EBIT
CNY 258.8M
EBITDA
CNY 344.2M
EPS
CNY 0.48
F Score
5
FCF
CNY 1.4B
FCF EV Yield
71.07x
FCF Per Share
CNY 14.28
Financing CF
-1,249,565,036
Fiscal Year End
December
Founded
2,001
Goodwill
434,211,850
Graham Number
15.42449
Graham Upside
-51.02
Income Tax
CNY 5M
Investing CF
-173,238,923
Is Primary Listing
1
Last Earnings Date
2026-04-21
Last Report Date
2026-03-31
Lynch Fair Value
CNY 12.05
Lynch Upside
-61.75
Ma150
27.35
Ma150ch
15.12%
Ma20
28.68
Ma20ch
9.79%
Net CF
149,944,014
Next Earnings Date
2026-08-14
Open
30.43
P FCF Ratio
2.21
P OCF Ratio
1.98
Payment Date
2025-05-15
Position In Range
67.52
Ppne
349,808,796
Price Date
2026-05-08
Price EBITDA
CNY 9.03
Ptbv Ratio
1.86
Relative Volume
2.16x
Revenue
3,939,317,187x
Tax By Revenue
0.13x
Tax Rate
2.02%
Tr6m
18.83%
Volume
5,531,553
Z Score
9.56
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHE/301290 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.8%
$0.24 annual per share
Payout ratio
+64.9%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
0 consecutive years of growth
Total shareholder yield
-0.1%
Next ex-dividend date: 2025-05-15
Performance

SHE/301290 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+40.5%
S&P 500 1Y: n/a
3Y total return
+5.7%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SHE/301290?

Insider, institutional, and short-interest positioning.

Institutional ownership
+12.0%
Share of float held by funds and institutions
Insider ownership
+37.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.8%
Negative means the company is buying back shares.
Technical

SHE/301290 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
69.3
Neutral momentum band
Price vs 200-day MA
+15.3%
50/200-day relationship not available
Beta (5Y)
0.70
Less volatile than the market
Sharpe ratio
1.03
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/301290

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301290 stock rating?

she/301290 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301290 analysis?

The full report lives at /stocks/she/301290/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301290?

The latest report frames she/301290 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301290 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.